A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma.
Nature Communications
Kong, Li Ren LR; Mohamed Salleh, Nur Afiqah Binte NAB; Ong, Richard Weijie RW; Tan, Tuan Zea TZ; Syn, Nicholas L NL; Goh, Robby Miguel RM; Fhu, Chee Wai CW; Tan, Daniel S W DSW; Iyer, N Gopalakrishna NG; Kannan, Srinivasaraghavan S; Verma, Chandra S CS; Lim, Yaw Chyn YC; Soo, Ross R; Ho, Jingshan J; Huang, Yiqing Y; Lim, Joline S J JSJ; Yan, Benedict Junrong BJ; Nga, Min En ME; Lim, Seng Gee SG; Koeffler, H Phillip HP; Lee, Soo Chin SC; Kappei, Dennis D; Hung, Huynh The HT; Goh, Boon Cher BC
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail.
British Journal Of Cancer
Ong, M M; Carreira, S S; Goodall, J J; Mateo, J J; Figueiredo, I I; Rodrigues, D N DN; Perkins, G G; Seed, G G; Yap, T A TA; Attard, G G; de Bono, J S JS
DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Yeh, Paul P; Chen, Heidi H; Andrews, Jenny J; Naser, Riyad R; Pao, William W; Horn, Leora L